Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia · Delayed Price · Currency is SAR 111.90
-1.10 (-0.97%)
May 21, 2026, 3:18 PM AST
Dallah Healthcare Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 467.23 | 538.27 | 471.2 | 360.12 | 274.46 | 258.6 |
Depreciation & Amortization | 237.83 | 220.13 | 140.07 | 124.35 | 114.15 | 115.11 |
Other Amortization | 4.55 | 4.55 | 0.42 | 1.26 | 0.11 | - |
Loss (Gain) From Sale of Assets | 0.87 | 0.43 | 0.05 | 0.1 | -1.07 | -0.19 |
Loss (Gain) on Equity Investments | -53.5 | -51.7 | -42.97 | 1.86 | 22.82 | 31.08 |
Provision & Write-off of Bad Debts | 49.65 | 49.63 | 30.4 | 29.26 | 6.05 | 17.1 |
Other Operating Activities | 195.87 | 120.3 | 137.63 | 151.8 | 143.08 | 68.27 |
Change in Accounts Receivable | -465.22 | -266.54 | -80.52 | -76.35 | -57.92 | -70.18 |
Change in Inventory | -48.58 | -68.12 | -34.36 | 30.46 | -38.69 | -52.21 |
Change in Accounts Payable | -32.09 | -16.71 | 55.23 | 7.78 | 25.94 | 29.25 |
Change in Other Net Operating Assets | 27.28 | 25.14 | 1.14 | -4.87 | -46.79 | -35.29 |
Operating Cash Flow | 383.89 | 555.39 | 678.29 | 625.78 | 442.13 | 361.55 |
Operating Cash Flow Growth | -50.70% | -18.12% | 8.39% | 41.54% | 22.29% | 97.24% |
Capital Expenditures | -448.18 | -465.29 | -363.64 | -294.51 | -172.69 | -115.62 |
Sale of Property, Plant & Equipment | 1.52 | 0.75 | 0 | 1.26 | 1.68 | 0.34 |
Cash Acquisitions | - | -313.82 | - | - | -9.45 | - |
Sale (Purchase) of Intangibles | -3.83 | -4.26 | -1.67 | -2.15 | -2.3 | -0.07 |
Investment in Securities | - | -8.7 | - | - | -0.28 | -313.81 |
Other Investing Activities | 2.9 | 3.92 | 8.17 | 1.71 | 3.93 | 3.86 |
Investing Cash Flow | -447.59 | -787.39 | -357.15 | -293.68 | -179.12 | -425.3 |
Long-Term Debt Issued | - | 2,421 | 720.16 | 233.37 | 724.51 | 730.73 |
Total Debt Issued | 2,259 | 2,421 | 720.16 | 233.37 | 724.51 | 730.73 |
Long-Term Debt Repaid | - | -1,313 | -752.41 | -296.38 | -675.77 | -394.79 |
Total Debt Repaid | -1,324 | -1,313 | -752.41 | -296.38 | -675.77 | -394.79 |
Net Debt Issued (Repaid) | 935.1 | 1,108 | -32.25 | -63 | 48.74 | 335.94 |
Repurchase of Common Stock | -29.11 | -13.57 | -60.46 | - | - | - |
Common Dividends Paid | -202.38 | -202.38 | -195.01 | -146.52 | -180 | -162.5 |
Other Financing Activities | -627.62 | -615.57 | -102.41 | -125.21 | -101.89 | -32.25 |
Financing Cash Flow | 75.99 | 276.24 | -390.12 | -334.74 | -233.15 | 141.19 |
Net Cash Flow | 12.3 | 44.24 | -68.98 | -2.64 | 29.87 | 77.43 |
Free Cash Flow | -64.28 | 90.1 | 314.65 | 331.28 | 269.44 | 245.93 |
Free Cash Flow Growth | - | -71.36% | -5.02% | 22.95% | 9.56% | 356.03% |
Free Cash Flow Margin | -1.51% | 2.22% | 9.81% | 11.26% | 10.83% | 11.68% |
Free Cash Flow Per Share | -0.63 | 0.89 | 3.23 | 3.40 | 2.99 | 2.73 |
Cash Interest Paid | 186.79 | 173.44 | 95.64 | - | 54.88 | 35.76 |
Levered Free Cash Flow | -449.61 | -220.16 | -137.56 | 110.12 | 110.49 | 94.56 |
Unlevered Free Cash Flow | -346.69 | -127.91 | -70.88 | 175.21 | 154.55 | 117.37 |
Change in Working Capital | -518.62 | -326.23 | -58.51 | -42.98 | -117.47 | -128.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.